Prestige Consumer Healthcare has completed the acquisition of the Breathe Right brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion. The deal, which closed on June 15, makes Breathe Right the company's largest brand with expected 2025 revenue of about $200 million and core profit of $95 million. The acquisition adds drug-free nasal strips to the portfolio and includes established brands such as Dimetapp, a children's cough and cold relief brand. While primarily distributed in the US, Breathe Right holds a leading category position with international growth opportunities. Prestige Consumer Healthcare is the largest independent provider of over-the-counter healthcare products in North America.
Prestige Brand Holdings IncPrestige completed a $1.045B acquisition of Breathe Right, adding a leading brand with $200M revenue and $95M core profit.
Foundation Consumer Healthcare sold Breathe Right and other brands, losing a major revenue-generating asset.